Rigid Corset Immobilisation of Patients Suffering From Spondylodiscitis: Practice Assessment
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 28, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients with spondylodiscitis, an infection of the spine, are currently treated, specifically focusing on the use of rigid corsets for immobilization. The study aims to gather information from both patients and healthcare workers to understand their experiences and practices in managing this condition.
To participate, patients need to be over 18 years old and hospitalized at Clermont-Ferrand University Hospital because of infectious spondylodiscitis. They should also be willing to share their experiences through an interview. Healthcare workers like doctors and nurses who care for these patients can also join the study. Participants can expect to be interviewed about their treatment experiences, which will help improve care for future patients. It’s important to note that individuals under 18 or those using a corset for non-infectious issues are not eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For patients:
- • Patients aged over 18,
- • Patients hospitalised at Clermont-Ferrand University Hospital with infectious spondylodiscitis,
- • Patient willing to be interviewed.
- For care workers:
- • - Doctors, nurses or care assistants involved in the care of patients hospitalised with spondylodiscitis.
- Exclusion Criteria:
- For patients :
- • Minor patients,
- • Patients wearing a corset for a non-infectious spinal pathology,
- • Patient refusing to take part in the study.
- For care workers:
- • - Doctor, nurse or nursing auxiliary refusing to take part in the study.
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Aurore MIGNE
Principal Investigator
University Hospital, Clermont-Ferrand
Orlane MENAGE
Principal Investigator
University Hospital, Clermont-Ferrand
Clémence RICHAUD
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported